STOCK TITAN

Calumet (CLMT) EVP Bruce Fleming awarded new restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Fleming Bruce A reported acquisition or exercise transactions in this Form 4 filing.

Calumet, Inc. executive Bruce A. Fleming reported awards of restricted stock units tied to the company’s common stock. On March 31, 2026, he received 13,047 restricted stock units that are 100% vested and will be settled on the earlier of a date he specifies or his termination date.

On the same date, he also received 4,349 restricted stock units under a Deferred Compensation Plan that will be settled on the earlier of a specified date or his termination. For this award, 25% of the units vest on July 1 of each year beginning on July 1, 2027. Each unit is the economic equivalent of one share of Calumet, Inc. common stock, so these are compensation-related equity grants rather than open-market share purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Fleming Bruce A
Role EVP - MONTANA RENEWABLES
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 13,047 $0.00 --
Grant/Award Restricted Stock Units 4,349 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 13,047 shares (Direct); Restricted Stock Units — 4,349 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.
RSU grant 1 13,047 restricted stock units Awarded March 31, 2026; 100% vested; settles at specified date or termination
RSU grant 2 4,349 restricted stock units Awarded March 31, 2026 under Deferred Compensation Plan
Vesting schedule 25% per year For 4,349-unit award, vesting each July 1 beginning July 1, 2027
Share equivalence 1 unit = 1 share Each Restricted Stock Unit equals one share of Calumet common stock
Restricted Stock Unit financial
"Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Deferred Compensation Plan financial
"settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan"
A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.
economic equivalent financial
"Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock"
vest financial
"25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fleming Bruce A

(Last)(First)(Middle)
1060 N CAPITOL AVE
SUITE 6-401

(Street)
INDIANAPOLIS INDIANA 46204

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP - MONTANA RENEWABLES
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)03/31/2026A13,047 (2) (2)Common Stock, par value $0.01 per share13,047$013,047D
Restricted Stock Units(1)03/31/2026A4,349 (3) (3)Common Stock, par value $0.01 per share4,349$04,349D
Explanation of Responses:
1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.
3. Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.
/s/ Connor J. Egan, as attorney-in-fact04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Calumet (CLMT) report for Bruce A. Fleming?

Calumet reported that EVP Bruce A. Fleming received two grants of restricted stock units on March 31, 2026. These equity awards are compensation-related and represent the right to receive Calumet common stock in the future, rather than open-market share purchases or sales.

How many restricted stock units did Bruce A. Fleming receive in this CLMT Form 4?

Bruce A. Fleming received one award of 13,047 restricted stock units and another award of 4,349 restricted stock units. Each restricted stock unit is the economic equivalent of one share of Calumet, Inc. common stock, providing future equity-based compensation exposure.

What are the vesting terms of Bruce A. Fleming’s CLMT restricted stock units?

One 13,047-unit award is 100% vested and will be settled on the earlier of a specified date or termination. The 4,349-unit award vests 25% each July 1, beginning July 1, 2027, with settlement on the earlier of a specified date or termination.

How and when will Bruce A. Fleming’s CLMT restricted stock units be settled?

Each restricted stock unit will be settled in connection with Calumet common stock on the earlier of a date specified by Bruce A. Fleming or his termination date. One grant is under the Deferred Compensation Plan, which governs the deferred settlement mechanics.

Are Bruce A. Fleming’s CLMT Form 4 transactions open-market buys or sells?

No, the Form 4 reports grant or award acquisitions of restricted stock units, not open-market trades. The transactions use code A, indicating compensation-related equity awards, so they do not represent buying or selling Calumet shares in the public market.